P/E của cổ phiếu QGEN là bao nhiêu?

Qiagen NV (QGEN) hiện giao dịch ở mức P/E 21.26 lần.

ROE của cổ phiếu QGEN là bao nhiêu?

Qiagen NV có tỷ suất lợi nhuận trên vốn chủ sở hữu (ROE) 12.07%.

Tỷ suất cổ tức của QGEN là bao nhiêu?

Qiagen NV có tỷ suất cổ tức 0.00%.

Điểm chất lượng (Quality Score) của QGEN là bao nhiêu?

AI của chúng tôi đánh giá chất lượng tài chính tổng thể của QGEN ở mức 77/100, dựa trên khả năng sinh lời, tăng trưởng, nợ và độ ổn định lợi nhuận.

Bây giờ có nên mua cổ phiếu QGEN không?

Điểm AI Timing của QGEN là 89/100, thể hiện mức độ hấp dẫn tương đối của giá hiện tại theo tín hiệu kỹ thuật và momentum — nên cân nhắc cùng điểm chất lượng và kế hoạch đầu tư của bạn.

Cổ phiếu QGEN thuộc ngành nào?

Qiagen NV được xếp vào ngành Healthcare >> Diagnostics & Research trên sàn NYSE

Cổ phiếu QGEN (NYSE) | QIAGEN NV – Phân tích Deepscope

Stock Check Daily update data at 8:30 AM
(Price: 2026-07-31 | FS: 2026-03-31)

QGEN AI Analysis Summary

Our AI summary for QGEN: Qiagen NV (NYSE), Healthcare >> Diagnostics & Research sector. The stock currently trades at a P/E of 21.26, ROE of 12.07%, a dividend yield of 0.00%. Its financial Quality Score stands at 77/100 — mid-range fundamentals relative to the market. The AI Timing Score is 89/100 — multiple technical signals currently support price momentum. All scores are recomputed automatically after each market close from official exchange data. This is systematically generated analysis, not personalized investment advice.

QGEN

Qiagen NV

US:NYSE STOCK Healthcare >> Diagnostics & Research News 87

USD 41.40

-0.05 (-0.12%) Day Change

Watchlist Portfolio Compare Chart

21.26

P/E

0.49

D/E

12.1%

ROE

7.0%

ROA

0.00%

Div Yield

0.19

PEG

QIAGEN NV
TYPE: STOCK
MARKET: NYSE

Compare Watchlist Myport

USD 41.40 Price -0.05 (-0.12%) Day Change	NEWS SCORE: 87

QGEN Chất lượng tổng thể của cố phiếu Tốt ( Chất lượng = 77) và Thời điểm mua ...(Sign In to See)...

Loading chart...

77 QUALITY

Signal: OUTPERFORM

Signal Description: Company financial health is Good

Reason: Tỷ lệ ROE tương đối thấp
Lịch sử ROE tương đối thấp
ROA quá thấp so với ROE

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Momentum indicators aligned on the daily timeframe

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt lắm , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Tốt , ...

Yếu tố Chất lượng

52%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	87
Magic Formula Rank by ROA	1277
Magic Formula Rank by ROE	1277
Magic Formula Rank by ROIC	1588
Price	41.40
PBV / Sector	2.57 / -29.69
Earning Per Share	1.95

PE / Sector	21.26 / 48.18
PEG or PE/Growth / Sector	0.19 / 1.64 GREAT
Average 1M Daily Value	104.24 M GREAT
Average 1W Daily Value	68.57 M

Yếu tố Kỹ thuật

71%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

72%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	19.16 / 13.01 GOOD
NPM Average (%) / Sector	16.17 / 7.90 GREAT
NPM Change Average (%) / Sector	71.89 / -6.69 GREAT
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	6.96 / 11.73
ROA Average (%) / Sector	5.50 / -87.10
ROA Change Average (%) / Sector	67.91 / 167.77 GREAT
ROE (%) / Sector	12.07 / -89.83
ROE Average (%) / Sector	9.37 / -2.30
ROE Change Average (%) / Sector	71.71 / -47.20 GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

41%

Dividend (%) / Sector	N/A / 0.18
Dividend Average (%) / Sector	3.51 / 1.19
Dividend Change Average (%) / Sector	17.13 / 4.52 GOOD

Chi tiết đăng ký

Analyze Date	2026-08-01 08:00:22
Symbol	QGEN
Name	QIAGEN NV
Sector	Healthcare >> Diagnostics & Research
Market	NYSE
Listed Shares	206.25 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	8,549.06 / 38,081.42

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Hulsterweg 82, Venlo, Netherlands, 5912 PL

Phone: 31 77 355 6600

Website: https://www.qiagen.com

Employees: 5,500

Sector: Healthcare >> Diagnostics & Research

Description: Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide. The company offers sample technology consumables, such as nucleic acid stabilization and purification kits for sample materials, manual and automated processing for genotyping, gene expression, and viral and bacterial analysis, as well as silica membranes and magnetic bead technologies; secondary sample technology consumables, including kits and components for purification of nucleic acids; and instruments for nucleic acid purification, quality control, and accessories. It also provides Immune response consumables, such as interferon-gamma release assay for TB testing, and assays for post-transplant testing and viral load monitoring; oncology and sexual and reproductive health consumables, inclsuing assays for prenatal testing and detection of sexually transmitted diseases and HPV; assays for analysis of genomic variants; and sample to insight instruments, including one-step molecular analysis of hard-to-diagnose syndromes, and integrated PCR testing. The company offers research PCR consumables, such as quantitative PCR, reverse transcription, and combinations kits for analysis of gene expression, genotyping and gene regulation, and running on QIAGEN instruments and technologies; human ID/forensics assay consumables comprising short tandem repeat assays for human ID, and assays for food contamination; PCR instruments, including digital PCR and qPCR solutions; and developed and configured enzymes and PCR solutions. It offers NGS gene panels, library prep kits and components, and whole genome amplification; DNA methylation analysis; QIAGEN consumables and instruments; bioinformatics solutions; and sequence-based assays forensic genetic genealog services. it provides software-as-a-service. It serves molecular diagnostics and life sciences sectors. The company was founded in 1984 and is headquartered in Venlo, the Netherlands.